Related Experiment Video
Updated: May 9, 2026

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Subclinical thyroid disease
Anukul Garg1, Mark P J Vanderpump
1Department of Endocrinology, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, UK.
British Medical Bulletin
|August 8, 2013
Summary
Subclinical thyroid disease is common, with controversial management. Research highlights risks of progression and benefits of intervention, especially in pregnancy, but guidelines vary.
Area of Science:
- Endocrinology
- Thyroidology
Background:
- Subclinical thyroid disease is frequently detected during thyroid function testing.
- Its clinical management is a subject of ongoing debate and controversy.
Purpose of the Study:
- To review epidemiological data on subclinical thyroid disease.
- To identify areas of agreement and controversy in its diagnosis and management.
- To highlight emerging research directions and timely areas for investigation.
Main Methods:
- Analysis of epidemiological data from large population studies in the USA and Europe.
- Review of existing meta-analyses concerning cardiovascular outcomes.
- Examination of diagnostic criteria and management guidelines.
Main Results:
- Subclinical thyroid disease is associated with an increased risk of progression to overt hypothyroidism or hyperthyroidism.
- Treatment of mild thyroid failure is crucial for optimizing pregnancy outcomes.
- Differences exist in long-term clinical outcomes between endogenous and exogenous subclinical hyperthyroidism.
Conclusions:
- Meta-analyses provide epidemiological insights into cardiovascular morbidity and mortality.
- Echocardiography and bone markers can help identify patients who may benefit from intervention.
- Randomized controlled trials are needed to determine the benefits of intervention for specific patient groups identified through screening.
Related Concept Videos
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...